Cargando…
Valproic Acid Reduces Neuroinflammation to Provide Retinal Ganglion Cell Neuroprotection in the Retina Axotomy Model
Neuroinflammation is a critical and targetable pathogenic component of neurodegenerative diseases, including glaucoma, the leading cause of irreversible blindness. Valproic acid has previously been demonstrated to reduce neuroinflammation and is neuroprotective in a number of experimental settings....
Autores principales: | Tribble, James R., Kastanaki, Elizabeth, Uslular, A. Berşan, Rutigliani, Carola, Enz, Tim J., Williams, Pete A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135180/ https://www.ncbi.nlm.nih.gov/pubmed/35646919 http://dx.doi.org/10.3389/fcell.2022.903436 |
Ejemplares similares
-
Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients
por: Rutigliani, Carola, et al.
Publicado: (2022) -
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection
por: Enz, Tim J., et al.
Publicado: (2021) -
In vivo Regeneration of Ganglion Cells for Vision Restoration in Mammalian Retinas
por: Xiao, Dongchang, et al.
Publicado: (2021) -
Microglial dynamics after axotomy-induced retinal ganglion cell death
por: Nadal-Nicolás, Francisco M., et al.
Publicado: (2017) -
On the Generation and Regeneration of Retinal Ganglion Cells
por: Oliveira-Valença, Viviane M., et al.
Publicado: (2020)